Key information
Publication type: General
Publication date:
Contents
The Mayor believes that protecting patients must be a priority for the Brexit negotiations.
Staying in the EU Single Market and Customs Union would ensure that patients can continue to have the same access to innovative treatments and clinical trials that could extend, save or improve lives. However, the UK Government’s commitment to leave both after Brexit is putting this at risk, and could inhibit the vital supply of medicines and medical technologies that currently flow between the UK and EU.
Download our report, Post-Brexit Access to Medicines and Medical Technologies, below.